- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Arrowhead Research Corporation (ARWR 0.96, -0.04, -3.88%) today announced that Dr. Christopher Anzalone, Chief Executive Officer, will be presenting at the Rodman & Renshaw Annual Global Investment Conference at 5:45 p.m. EDT on Tuesday, September 14, 2010, at the Palace Hotel in New York, NY. Dr. Anzalone will be discussing the Company and its increased focus on its nanomedicine portfolio, including clinical results.
Professional investors attending the conference are encouraged to schedule a one-on-one meeting with management by emailing
The presentation will be webcast live and is available for viewing at Arrowhead's website at www.arrowheadresearch.com under the "Investor Relations" section by selecting the "Presentations and Events," tab. An archive of the presentation will be available for 90 days following the conference.
Arrowhead recommends registering at least 10 minutes prior to the start of the presentation to ensure timely access.
About Arrowhead Research Corporation
Arrowhead Research Corporation (ARWR 0.96, -0.04, -3.88%) is a nanotechnology company commercializing new technologies in the areas of life sciences and electronics. Arrowhead is seeking to build value for shareholders through the progress of its subsidiaries and investments. Currently, Arrowhead is focused primarily on its two majority owned subsidiaries; Unidym, a leader in carbon nanotube technology for electronic applications, and Calando, at the forefront of clinical application of RNAi delivery technology. Arrowhead also has minority investments in two privately held nanobiotech companies.
For more information, please click here
The Piacente Group
Copyright © Arrowhead Research CorporationIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Richards-Kortum elected to American Academy of Arts and Sciences: April 22nd, 2015
Harris & Harris Group Sponsors NYC American Heart Association's Health Sciences Innovation Investment Forum: Co-founder of Harris & Harris Group Portfolio Company TARA Biosystems to Speak About the Value of Tissue Engineering Technology April 21st, 2015
Long Island Capital Alliance Announces Participants for Brookhaven National Laboratory Technology Transfer Capital Forum on May 8: Keynote Speaker Dr. Doon Gibbs, Director of Brookhaven National Laboratory April 16th, 2015
Rafts on the cell membrane: Researchers from TU Wien (Vienna) shed light on a big secret of cell membranes: The 'lipid rafts', which have been believed to move within the cell membrane, do not really exist April 21st, 2015